Delivery Order SPE2DB20D1110-SPE2DB22FK00U
Award Date
4/13/22
Potential Completion Date
4/14/22
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide TRINTELLIX 20 MG TABLET 30S, a pharmaceutical product, with a potential value of $1,365.27 and a period of performance through January 29, 2024. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA to deliver a comprehensive range of...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract worth $9,693.41 by the Defense Logistics Agency (DLA) to provide TRINTELLIX 20 MG TABLET 30S, a pharmaceutical product. The contract has a completion date of March 7, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order (SPE2DB22D1202|SPE2DB24FUWV1) worth $1,510.80 for the supply of TRINTELLIX 10 MG TABLETs. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,173.07 firm fixed-price delivery order is for the supply of TRINTELLIX 10 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of December 6, 2024 and does not include any set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRINTELLIX 10 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $1,325.52 and a period of performance through March 12, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a $1,746.21 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of 4564604011 TRINTELLIX 10 MG TABLET 30S, a prescription pharmaceutical product, with a performance period ending on May 15, 2024. Amerisourcebergen Drug Corp holds a single-award Indefinite Delivery Contract (IDC)...
Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract worth $2,282.58 by the Defense Logistics Agency (DLA) to provide TRINTELLIX 5 MG TABLET 30S. This delivery order has a completion date of January 29, 2024. Amerisourcebergen Drug Corp serves as a prime contractor supplying a wide range of pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of Defense...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563453553 - TRINTELLIX 20 MG TABLET 30S. The contract has a potential value of $1,691.95 and a completion date of January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. The company holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,499.40 firm-fixed-price delivery order is for the supply of TRINTELLIX 10 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of December 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The Delivery Order, valued at $1,933.17, is for the supply of Trintellix 10 mg tablets. This contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. Under this IDC, Amerisourcebergen provides a range of pharmaceutical products and medical...